Brief: Ryvu Therapeutics FY Net Loss At 111.4 Mln Zlotys
13/03/2025 05:42
March 13 (Reuters) - Ryvu Therapeutics SA RVU.WA: FY NET LOSS 111.44 MILLION ZLOTYS FY OPERATING REVENUE 102.0 MILLION ZLOTYS FY OPERATING LOSS 122.1 MILLION ZLOTYS Source text: ID:nEM6PCpLla Further company coverage: RVU.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys